Phase 4
Completed N=70
Morphine Added to Ropivacaine for FICB for Postoperative Analgesia
Source: ClinicalTrials.gov NCT03875274 ↗Enrolled (actual)
70
Serious AEs
0.0%
Results posted
Mar 2023
Primary outcomePrimary: Duration of Analgesia — 541; 634 minutes
◆ Published Evidence
No publication linked
No peer-reviewed publication reporting this trial's results has been linked yet. This can indicate results are unpublished — a known publication-bias signal. We re-check periodically.
Summary
prospective, randomized double blinded study to investigate the effects of morphine as an adjuvant to ropivacaine on FICB
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Duration of Analgesia |
541; 634 | — |
Eligibility Criteria
Inclusion Criteria
- All patients undergoing elective femur surgery under spinal anaesthesia
- Age group (18-65 years)
- ASA physical status I and II
Exclusion Criteria
- • Not willing to participate in the study
- Other painful co-morbidities (neuropathies)
- Allergy or any contraindication to study medication
- Psychiatric disorder
- Coagulopathy
- Infection at the site of the block
- Use of other modes of anaesthesia or analgesia besides spinal anaesthesia.
Data sourced from ClinicalTrials.gov (NCT03875274). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.